Umbilical Cord Blood Collection and Processing for Pre-clinical Cardiac Regeneration


About this study

The purpose of this study is to serve as the foundation to determine if a larger clinical study may be beneficial with the goal of establishing cord blood as a cell source to treat congenital heart disease for unhealthy babies.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:    

  • Patients age 18 and older in their second or third trimester of normal pregnancy will be eligible to participate in this research study.   

Exclusion Criteria:   

  • Abnormal pregnancy that may include birth defects of the fetus, maternal complications with the placenta or umbilical cord anatomy, and/or any complications during the birthing process.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Susana Cantero Peral, M.D., Ph.D.

Closed for enrollment

Eau Claire, Wis.

Mayo Clinic principal investigator

Blenda Yun, M.D.

Closed for enrollment

More information


Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions